Point Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Jun 12, 2013 - MarketLine - 60 pages - USD $350
Abstract Table of Contents Companies Request Details Related
PRINT & SHARE
MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

MarketLines' Point Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Point Therapeutics, Inc. since January 2007.

Scope:
  • Provides intelligence on Point Therapeutics, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
  • Detailed reports of various financial transactions undertaken by Point Therapeutics, Inc. and its subsidiaries since 2007.
  • Information about key financial and legal advisors for Point Therapeutics, Inc.'s financial deals transactions.
  • Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:

This report includes Point Therapeutics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Point Therapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:
  • Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
  • Form an independent opinion about Point Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007.
  • Track your competitors' business structure and growth strategies.

Order This Report
FORMAT: PDF $350 USD
LICENSE: Single-User
DELIVERY: Instant Download

EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away


About the Publisher
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. MarketLine is wholly owned subsidiary of Datamonitor.